Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation

Nature Communications

Volumn 6, Issue , 2015, Pages

  Cheng, Jingdong ^a,b,c   Yang, Huirong ^a,b,c   Fang, Jian ^a   Ma, Lixiang ^d   Gong, Rui ^a   Wang, Ping ^a   Li, Ze ^a   Xu, Yanhui ^a,b,c  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c FUDAN UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITINASE; DNA METHYLTRANSFERASE 1; HISTONE DEACETYLASE INHIBITOR; UBIQUITIN SPECIFIC PROTEASE 7; UNCLASSIFIED DRUG; DMAP1 PROTEIN, HUMAN; REPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE; USP7 PROTEIN, HUMAN;

CANCER; CELLS AND CELL COMPONENTS; CRYSTAL STRUCTURE; INHIBITOR; METHYLATION; MOLECULAR ANALYSIS; PROTEIN;

ARTICLE; CHROMATIN; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME BINDING; ENZYME DEGRADATION; ENZYME STABILITY; HUMAN; HUMAN CELL; NERVE CELL; PROTEIN ACETYLATION; PROTEIN PROTEIN INTERACTION; ACETYLATION; CHEMISTRY; CRYSTALLIZATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR MODEL; MUTATION; PHYSIOLOGY; PROTEIN CONFORMATION; TUMOR CELL LINE;

ACETYLATION; CELL LINE, TUMOR; CRYSTALLIZATION; GENE EXPRESSION REGULATION; HUMANS; MODELS, MOLECULAR; MUTATION; PROTEIN CONFORMATION; REPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84929178504     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8023     Document Type: Article

References (52)

1. Smith, Z. D. & Meissner, A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204-220 (2013).
2. Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33 (Suppl), 245-254 (2003).
3. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21 (2002).
4. Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome- biological and translational implications. Nat. Rev. Cancer 11, 726-734 (2011).
5. Goll, M. G. & Bestor, T. H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem. 74, 481-514 (2005).
6. Bostick, M. et al. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317, 1760-1764 (2007).
7. Sharif, J. et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450, 908-912 (2007).
8. Karagianni, P., Amazit, L., Qin, J. & Wong, J. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol. Cell Biol. 28, 705-717 (2008).
9. Subramaniam, D., Thombre, R., Dhar, A. & Anant, S. DNA methyltransferases: a novel target for prevention and therapy. Front. Oncol. 4, 80 (2014).
10. Kinney, S. R. & Pradhan, S. Regulation of expression and activity of DNA (cytosine-5) methyltransferases in mammalian cells. Prog. Mol. Biol. Transl. Sci. 101, 311-333 (2011).
11. Denis, H., Ndlovu, M. N. & Fuks, F. Regulation of mammalian DNA methyltransferases: a route to new mechanisms. EMBO Rep. 12, 647-656 (2011).
12. Qin, W., Leonhardt, H. & Pichler, G. Regulation of DNA methyltransferase 1 by interactions and modifications. Nucleus 2, 392-402 (2011).
13. Esteve, P. O. et al. Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc. Natl Acad. Sci. USA 106, 5076-5081 (2009).
14. Wang, J. et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat. Genet. 41, 125-129 (2009).
15. Zhou, Q., Agoston, A. T., Atadja, P., Nelson, W. G. & Davidson, N. E. Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells. Mol. Cancer Res. 6, 873-883 (2008).
16. Du, Z. et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci. Signal. 3, ra80 (2010).
17. Felle, M. et al. The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1. Nucleic Acids Res. 39, 8355-8365 (2011).
18. Qin, W., Leonhardt, H. & Spada, F. Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1. J. Cell Biochem. 112, 439-444 (2011).
19. Nicholson, B. & Suresh Kumar, K. G. The multifaceted roles of USP7: new therapeutic opportunities. Cell Biochem. Biophys. 60, 61-68 (2011).
20. Everett, R. D. et al. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16, 566-577 (1997).
21. van der Knaap, J. A. et al. GMP synthetase stimulates histone H2B deubiquitylation by the epigenetic silencer USP7. Mol. Cell 17, 695-707 (2005).
22. Faesen, A. C. et al. Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. Mol. Cell 44, 147-159 (2011).
23. Dar, A., Shibata, E. & Dutta, A. Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway. Mol. Cell Biol. 33, 3309-3320 (2013).
24. Ma, H. et al. M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability. Proc. Natl Acad. Sci. USA 109, 4828-4833 (2012).
25. Hussain, S., Zhang, Y. & Galardy, P. J. DUBs and cancer: the role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors. Cell Cycle 8, 1688-1697 (2009).
26. Song, M. S. et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455, 813-817 (2008).
27. Song, J., Rechkoblit, O., Bestor, T. H. & Patel, D. J. Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science 331, 1036-1040 (2011).
28. Kim, S. C. et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23, 607-618 (2006).
29. Choudhary, C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840 (2009).
30. Wang, W., Gao, J., Man, X. H., Li, Z. S. & Gong, Y. F. Significance of DNA methyltransferase-1 and histone deacetylase-1 in pancreatic cancer. Oncol. Rep. 21, 1439-1447 (2009).
31. Peng, D. F. et al. Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas. Cancer Sci. 96, 403-408 (2005).
32. Deer, E. L. et al. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 39, 425-435 (2010).
33. Han, H., Yang, X., Pandiyan, K. & Liang, G. Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells. PloS ONE 8, e75136 (2013).
34. Fonseca-Silva, T. et al. Analysis of p16(CDKN2A) methylation and HPV-16 infection in oral mucosal dysplasia. Pathobiology 79, 94-100 (2012).
35. Kumagai, T. et al. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells. Int. J. Cancer 121, 656-665 (2007).
36. Ma, L. et al. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell 10, 455-464 (2012).
37. Kantarjian, H. et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer 106, 1794-1803 (2006).
38. Silverman, L. R. et al. Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B. J. Clin. Oncol. 24, 3895-3903 (2006).
39. Shaker, S., Bernstein, M., Momparler, L. F. & Momparler, R. L. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza- 2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells. Leuk. Res. 27, 437-444 (2003).
40. Hurtubise, A., Bernstein, M. L. & Momparler, R. L. Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells. Cancer Cell Int. 8, 16 (2008).
41. Gius, D. et al. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 6, 361-371 (2004).
42. Alhosin, M. et al. Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J. Exp. Clin. Cancer Res. 30, 41 (2011).
43. Hu, M. et al. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway. PLoS Biol. 4, e27 (2006).
44. Saridakis, V. et al. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol. Cell 18, 25-36 (2005).
45. Holowaty, M. N., Sheng, Y., Nguyen, T., Arrowsmith, C. & Frappier, L. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J. Biol. Chem. 278, 47753-47761 (2003).
46. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
47. McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658-674 (2007).
48. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. 60, 2126-2132 (2004).
49. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. 58, 1948-1954 (2002).
50. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thornton, J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291 (1993).
51. DeLano, W. L. The PyMOL Molecular Graphics System http://www.pymol.org (2002).
52. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).